target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id
kinase insert domain receptor,1813,P35968,Human,dorsomorphin,4907,,11524144,C1CCN(CC1)CCOc1ccc(cc1)c1cnc2n(c1)ncc2c1ccncc1,"InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2",XHBVYDAKJHETMP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.4,,IC50,,4.0,,=,"Assayed using AMPK heterotrimeric complex containing &alpha;2, &beta;1, &gamma;1 subunits",,,20932747,
kinase insert domain receptor,1813,P35968,Human,semaxanib,5056,,5329098,O=C1Nc2c(/C/1=C/c1[nH]c(cc1C)C)cccc2,"InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-",WUWDLXZGHZSWQZ-WQLSENKSSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.7,,IC50,,200.0,,=,,,,10882357,
kinase insert domain receptor,1813,P35968,Human,VEGFA,5085,Human,,,,,Agonist,Agonist,,,,,pKd,,9.64,,Kd,,0.23,,=,Dissociation constant for scVEGF-binding to dimeric VEGFR2.,,,31023826,
kinase insert domain receptor,1813,P35968,Human,VEGFA,5085,Human,,,,,Agonist,Agonist,,,,,pKd,,8.0,,Kd,,10.0,,=,Dissociation constant for scVEGF-binding to monomeric VEGFR2.,,,31023826,
kinase insert domain receptor,1813,P35968,Human,linifanib,5657,,11485656,O=C(Nc1cc(C)ccc1F)Nc1ccc(cc1)c1cccc2c1c(N)n[nH]2,"InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)",MPVGZUGXCQEXTM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.4,,IC50,,4.0,,=,,,,16648571,
kinase insert domain receptor,1813,P35968,Human,axitinib,5659,,6450551,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1,"InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+",RITAVMQDGBJQJZ-FMIVXFBMSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,9.6,,IC50,,0.25,,=,,,,20869793,
kinase insert domain receptor,1813,P35968,Human,axitinib,5659,,6450551,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1,"InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+",RITAVMQDGBJQJZ-FMIVXFBMSA-N,Inhibitor,Inhibition,,,yes,,pKd,,8.23,,Kd,,5.9,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,motesanib,5660,,11667893,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.52,,IC50,,3.0,,=,,,,23098265,
kinase insert domain receptor,1813,P35968,Human,motesanib,5660,,11667893,O=C(c1cccnc1NCc1ccncc1)Nc1ccc2c(c1)NCC2(C)C,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKd,,8.59,,Kd,,2.6,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,AST-487,5661,,11409972,CCN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)Nc1ccc(cc1)Oc1ncnc(c1)NC,"InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)",ODPGGGTTYSGTGO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.77,,IC50,,170.0,,=,<i>In vitro</i> inhibition of KDR.,,,17638907,
kinase insert domain receptor,1813,P35968,Human,cediranib,5664,,9933475,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C,"InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3",XXJWYDDUDKYVKI-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,9.0,,IC50,,1.0,,<,,,,15899831,
kinase insert domain receptor,1813,P35968,Human,cediranib,5664,,9933475,COc1cc2c(ncnc2cc1OCCCN1CCCC1)Oc1ccc2c(c1F)cc([nH]2)C,"InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3",XXJWYDDUDKYVKI-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKd,,8.96,,Kd,,1.1,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,brivanib,5671,,11234052,C[C@H](COc1cn2c(c1C)c(ncn2)Oc1ccc2c(c1F)cc([nH]2)C)O,"InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1",WCWUXEGQKLTGDX-LLVKDONJSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.6,,IC50,,25.0,,=,,,,16570908,
kinase insert domain receptor,1813,P35968,Human,foretinib,5679,,42642645,COc1cc2c(ccnc2cc1OCCCN1CCOCC1)Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",CXQHYVUVSFXTMY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,9.1,,8.17,IC50,6.8,,0.8,=,,,,23098265,
kinase insert domain receptor,1813,P35968,Human,Ki-20227,5690,,9869779,COc1cc(ccc1NC(=O)NC(c1nccs1)C)Oc1ccnc2c1cc(OC)c(c2)OC,"InChI=1S/C24H24N4O5S/c1-14(23-26-9-10-34-23)27-24(29)28-17-6-5-15(11-20(17)30-2)33-19-7-8-25-18-13-22(32-4)21(31-3)12-16(18)19/h5-14H,1-4H3,(H2,27,28,29)",SHPFDGWALWEPGS-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.92,,IC50,,12.0,,=,,,,17121910,
kinase insert domain receptor,1813,P35968,Human,pazopanib,5698,,10113978,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C,"InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)",CUIHSIWYWATEQL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.52,,IC50,,30.0,,=,,,,18620382,
kinase insert domain receptor,1813,P35968,Human,pazopanib,5698,,10113978,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C,"InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)",CUIHSIWYWATEQL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKd,,7.85,,Kd,,14.0,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,PLX-4720,5703,,24180719,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(Cl)cn2)F,"InChI=1S/C17H14ClF2N3O3S/c1-2-5-27(25,26)23-13-4-3-12(19)14(15(13)20)16(24)11-8-22-17-10(11)6-9(18)7-21-17/h3-4,6-8,23H,2,5H2,1H3,(H,21,22)",YZDJQTHVDDOVHR-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKi,,8.05,,Ki,,9.0,,=,,,,12538485,
kinase insert domain receptor,1813,P35968,Human,vatalanib,5705,,151194,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1,"InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)",YCOYDOIWSSHVCK-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.68,,IC50,,21.0,,=,,,,16321531,
kinase insert domain receptor,1813,P35968,Human,vatalanib,5705,,151194,Clc1ccc(cc1)Nc1nnc(c2c1cccc2)Cc1ccncc1,"InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)",YCOYDOIWSSHVCK-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKd,,7.21,,Kd,,62.0,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,sorafenib,5711,,216239,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.05,,IC50,,90.0,,=,,,,21613405,
kinase insert domain receptor,1813,P35968,Human,sorafenib,5711,,216239,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.05,,IC50,,90.0,,=,,,,15466206,
kinase insert domain receptor,1813,P35968,Human,sorafenib,5711,,216239,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pKd,,7.23,,Kd,,59.0,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,SU-14813,5712,,73755145,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1\C(=O)Nc2c1cc(F)cc2)C,"InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,21,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-,21?/m0/s1",XWPFYHDOZULRTD-ROUJOJKSSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.3,,IC50,,50.0,,=,,,,16891463,
kinase insert domain receptor,1813,P35968,Human,SU-14813,5712,,73755145,O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1\C(=O)Nc2c1cc(F)cc2)C,"InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,21,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-,21?/m0/s1",XWPFYHDOZULRTD-ROUJOJKSSA-N,Inhibitor,Inhibition,,,yes,,pKd,,8.64,,Kd,,2.3,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,sunitinib,5713,,5329102,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cc(F)cc2)CC,"InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,Inhibitor,Inhibition,,,,,pIC50,,7.65,,IC50,,22.6,,=,,,,20570526,
kinase insert domain receptor,1813,P35968,Human,vandetanib,5717,,3081361,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",UHTHHESEBZOYNR-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.0,,IC50,,9.0,,=,,,,15743202,
kinase insert domain receptor,1813,P35968,Human,cabozantinib,5887,,25102847,COc1cc2c(ccnc2cc1OC)Oc1ccc(cc1)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F,"InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)",ONIQOQHATWINJY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,10.46,,IC50,,0.035,,=,,,,21926191,
kinase insert domain receptor,1813,P35968,Human,regorafenib,5891,,11167602,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",FNHKPVJBJVTLMP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.9,,IC50,,13.0,,,,,,21170960,
kinase insert domain receptor,1813,P35968,Human,nintedanib,5936,,135423438,COC(=O)c1ccc2c(c1)NC(=O)/C/2=C(/c1ccccc1)\Nc1ccc(cc1)N(C(=O)CN1CCN(CC1)C)C,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-",XZXHXSATPCNXJR-ZIADKAODSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.68,,IC50,,21.0,,=,,,,18559524,
kinase insert domain receptor,1813,P35918,Mouse,DMBI,5958,,5353593,O=C1Nc2c(/C/1=C\c1ccc(cc1)N(C)C)cccc2,"InChI=1S/C17H16N2O/c1-19(2)13-9-7-12(8-10-13)11-15-14-5-3-4-6-16(14)18-17(15)20/h3-11H,1-2H3,(H,18,20)/b15-11+",UAKWLVYMKBWHMX-RVDMUPIBSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,6.1,,IC50,,794.0,,=,,,,10956210,
kinase insert domain receptor,1813,P35968,Human,dovitinib,5962,,9886808,CN1CCN(CC1)c1ccc2c(c1)[nH]/c(=C/1\C(=O)N=c3c(=C1N)c(F)ccc3)/[nH]2,"InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11,24-25H,7-10,23H2,1H3/b20-18-",KCOYQXZDFIIGCY-ZZEZOPTASA-N,Inhibitor,Inhibition,,,,,pIC50,,,,IC50,65.0,,13.0,=,,,,19113866|15598814,
kinase insert domain receptor,1813,P35968,Human,SU11652,6043,,5329103,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cc(Cl)cc2)CC,"InChI=1S/C22H27ClN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",XPLJEFSRINKZLC-ATVHPVEESA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.57,,IC50,,27.0,,=,,,,12646019,
kinase insert domain receptor,1813,P35918,Mouse,VEGF receptor 2 kinase inhibitor I,6053,,6419834,CCOC(=O)c1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cccc2,"InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9-",PMUJUSJUVIXDQC-LCYFTJDESA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.15,,IC50,,70.0,,=,,,,9651163,
kinase insert domain receptor,1813,P35968,Human,VEGF receptor 2 kinase inhibitor II,6054,,5329155,Brc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)/C(=O)N2,"InChI=1S/C17H15BrN2O/c18-11-5-6-16-13(8-11)14(17(21)20-16)9-12-7-10-3-1-2-4-15(10)19-12/h5-9,19H,1-4H2,(H,20,21)/b14-9-",RFHPWPWVGFSLOP-ZROIWOOFSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.15,,IC50,,70.0,,=,,,,10893303,
kinase insert domain receptor,1813,P35968,Human,VEGF receptor 2 kinase inhibitor IV,6055,,5329468,COc1ccc(cc1)c1cnc2n(c1)ncc2c1cscc1,"InChI=1S/C17H13N3OS/c1-21-15-4-2-12(3-5-15)14-8-18-17-16(9-19-20(17)10-14)13-6-7-22-11-13/h2-11H,1H3",HBWLNACPIFKNIP-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.72,,IC50,,19.0,,=,,,,12443771,
kinase insert domain receptor,1813,P35968,Human,VEGF receptor tyrosine kinase inhibitor II,6056,,9797919,Clc1ccc(cc1)NC(=O)c1ccccc1NCc1ccncc1,"InChI=1S/C19H16ClN3O/c20-15-5-7-16(8-6-15)23-19(24)17-3-1-2-4-18(17)22-13-14-9-11-21-12-10-14/h1-12,22H,13H2,(H,23,24)",GGPZCOONYBPZEW-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,7.82,,Ki,,15.0,,=,,,,17869515,
kinase insert domain receptor,1813,P35968,Human,VEGF receptor tyrosine kinase inhibitor III,6057,,9549295,CCCNC(=O)Nc1ccc(cc1Cl)Oc1ncnc2c1cc(OC)c(c2)OC,"InChI=1S/C20H21ClN4O4/c1-4-7-22-20(26)25-15-6-5-12(8-14(15)21)29-19-13-9-17(27-2)18(28-3)10-16(13)23-11-24-19/h5-6,8-11H,4,7H2,1-3H3,(H2,22,25,26)",VPBYZLCHOKSGRX-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,9.0,,IC50,,1.0,,=,,,,18077363,
kinase insert domain receptor,1813,P35968,Human,tivozanib,6058,,9911830,COc1cc2c(ccnc2cc1OC)Oc1ccc(c(c1)Cl)NC(=O)Nc1noc(c1)C,"InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)",SPMVMDHWKHCIDT-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,9.8,,IC50,,0.16,,=,,,,23098265,
kinase insert domain receptor,1813,P35968,Human,ramucirumab,7390,,,,,,Antibody,Antagonist,,,yes,,pIC50,,9.0,,IC50,,1.0,,=,,,,12917408,
kinase insert domain receptor,1813,P35968,Human,ramucirumab,7390,,,,,,Antibody,Antagonist,,,yes,,pKd,,10.3,,Kd,,0.05,,=,,,,12917408,
kinase insert domain receptor,1813,P35968,Human,lenvatinib,7426,,9823820,COc1cc2nccc(c2cc1C(=O)N)Oc1ccc(c(c1)Cl)NC(=O)NC1CC1,"InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)",WOSKHXYHFSIKNG-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.4,,IC50,,4.0,,=,,,,23098265,
kinase insert domain receptor,1813,P35968,Human,AEE788,7643,,16035342,CCN1CCN(CC1)Cc1ccc(cc1)c1cc2c([nH]1)ncnc2N[C@@H](c1ccccc1)C,"InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1",OONFNUWBHFSNBT-HXUWFJFHSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.11,,IC50,,77.0,,=,,,,15256466,
kinase insert domain receptor,1813,P35968,Human,rivoceranib,7648,,11315474,N#CC1(CCCC1)c1ccc(cc1)NC(=O)c1cccnc1NCc1ccncc1,"InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)",WPEWQEMJFLWMLV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,9.0,,IC50,,1.0,,=,Assay used apatinib mesylate (YN968D1),,,21443688,
kinase insert domain receptor,1813,P35968,Human,lucitanib,7649,,25031915,CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1,"InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)",CUDVHEFYRIWYQD-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.4,,IC50,,4.0,,=,,,,22304225,
kinase insert domain receptor,1813,P35968,Human,AZD4547,7707,,51039095,COc1cc(CCc2[nH]nc(c2)NC(=O)c2ccc(cc2)N2C[C@H](C)N[C@@H](C2)C)cc(c1)OC,"InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+",VRQMAABPASPXMW-HDICACEKSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.62,,IC50,,24.0,,=,,,,,
kinase insert domain receptor,1813,P35968,Human,orantinib,7816,,5329099,OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cccc2,"InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-",NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,6.17,,IC50,,680.0,,=,,,,19110422,
kinase insert domain receptor,1813,P35968,Human,infigratinib,7877,,53235510,CCN1CCN(CC1)c1ccc(cc1)Nc1ncnc(c1)N(C(=O)Nc1c(Cl)c(OC)cc(c1Cl)OC)C,"InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H,32,36)(H,29,30,31)",QADPYRIHXKWUSV-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.74,,IC50,,180.0,,=,,,,21936542,
kinase insert domain receptor,1813,P35968,Human,BMS-690514,7879,,11349170,COc1cccc(c1)Nc1ncnn2c1c(cc2)CN1CC[C@H]([C@@H](C1)O)N,"InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1",CSGQVNMSRKWUSH-IAGOWNOFSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.3,,IC50,,50.0,,=,,,,20166197,
kinase insert domain receptor,1813,P35968,Human,CP-547632,7881,,9811611,O=C(Nc1snc(c1C(=O)N)OCc1c(F)cc(cc1F)Br)NCCCCN1CCCC1,"InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)",HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.96,,IC50,,11.0,,=,,,,14612527,
kinase insert domain receptor,1813,P35968,Human,ENMD-2076,7885,,16041424,CN1CCN(CC1)c1nc(/C=C/c2ccccc2)nc(c1)Nc1n[nH]c(c1)C,"InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+",BLQYVHBZHAISJM-CMDGGOBGSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.44,,IC50,,36.0,,=,,,,19320489,
kinase insert domain receptor,1813,P35968,Human,famitinib,7886,,16662431,CCN(CCN1CCc2c(C1=O)c(C)c([nH]2)/C=C/1\C(=O)Nc2c1cc(F)cc2)CC,"InChI=1S/C23H27FN4O2/c1-4-27(5-2)10-11-28-9-8-19-21(23(28)30)14(3)20(25-19)13-17-16-12-15(24)6-7-18(16)26-22(17)29/h6-7,12-13,25H,4-5,8-11H2,1-3H3,(H,26,29)/b17-13-",GKEYKDOLBLYGRB-LGMDPLHJSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.3,,IC50,,5.0,,=,,,,21028894,
kinase insert domain receptor,1813,P35968,Human,tesevatinib,7944,,10458325,COc1cc2c(cc1OCC1C[C@@H]3[C@H](C1)CN(C3)C)ncnc2Nc1ccc(c(c1F)Cl)Cl,"InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+",HVXKQKFEHMGHSL-GOOCMWNKSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.82,,IC50,,1.5,,=,,,,17575237,
kinase insert domain receptor,1813,P35968,Human,golvatinib,7956,,16118392,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1nccc(c1)Oc1ccc(c(c1)F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F,"InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)",UQRCJCNVNUFYDX-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.8,,IC50,,16.0,,=,Measured as inhibition of VEGFR-2 autophosphorylation in HUVEC cells.,,,19832844,
kinase insert domain receptor,1813,P35968,Human,MK-2461,7962,,44137946,Cn1ncc(c1)c1cnc2c(c1)c(=O)c1cc(ccc1cc2)NS(=O)(=O)N(C[C@@H]1COCCO1)C,"InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1",JGEBLDKNWBUGRZ-HXUWFJFHSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.36,,IC50,,44.0,,=,,,,20145145,
kinase insert domain receptor,1813,P35968,Human,BX-795,8006,,10077147,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCCNC(=O)c1cccs1)I,"InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)",VAVXGGRQQJZYBL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,5.96,,IC50,,1100.0,,=,,,,15772071,
kinase insert domain receptor,1813,P35968,Human,BX-912,8007,,11754511,O=C(N1CCCC1)Nc1cccc(c1)Nc1ncc(c(n1)NCCc1cnc[nH]1)Br,"InChI=1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28)",DMMILYKXNCVKOJ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.39,,IC50,,410.0,,=,,,,15772071,
kinase insert domain receptor,1813,P35968,Human,PP121,8013,,24905142,Nc1ncnc2c1c(nn2C1CCCC1)c1cnc2c(c1)cc[nH]2,"InChI=1S/C17H17N7/c18-15-13-14(11-7-10-5-6-19-16(10)20-8-11)23-24(12-3-1-2-4-12)17(13)22-9-21-15/h5-9,12H,1-4H2,(H,19,20)(H2,18,21,22)",NVRXTLZYXZNATH-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.92,,IC50,,12.0,,=,,,,18849971,
kinase insert domain receptor,1813,P35968,Human,BIBF-1202,8096,,11606145,CN1CCN(CC1)CC(=O)N(c1ccc(cc1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)O)/c1ccccc1)C,"InChI=1S/C30H31N5O4/c1-33-14-16-35(17-15-33)19-26(36)34(2)23-11-9-22(10-12-23)31-28(20-6-4-3-5-7-20)27-24-13-8-21(30(38)39)18-25(24)32-29(27)37/h3-13,18,31H,14-17,19H2,1-2H3,(H,32,37)(H,38,39)/b28-27-",KEHNCEDHZGQSNP-DQSJHHFOSA-N,Inhibitor,Inhibition,,,,,pKd,,8.54,,Kd,,2.9,,=,,,,22037378,
kinase insert domain receptor,1813,P35968,Human,LY2874455,8104,,46944259,OCCn1ncc(c1)/C=C/c1n[nH]c2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C,"InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+/t13-/m1/s1",GKJCVYLDJWTWQU-CXLRFSCWSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.15,,IC50,,7.0,,=,<i>In vitro</i> biochemical assay result,,,21900693,
kinase insert domain receptor,1813,P35968,Human,compound 13a [PMID: 23639540],8155,,60182393,O1CCN(CC1)c1ccc(cc1)c1cnc2n(c1)ncc2c1cn[nH]c1,"InChI=1S/C19H18N6O/c1-3-17(24-5-7-26-8-6-24)4-2-14(1)16-9-20-19-18(12-23-25(19)13-16)15-10-21-22-11-15/h1-4,9-13H,5-8H2,(H,21,22)",WCDLCPLAAKUJNY-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,8.77,,IC50,,1.68,,=,,,,23639540,
kinase insert domain receptor,1813,P35968,Human,compound 8h [PMID: 22765894],8175,,67161540,CCN1CCC(CC1)Nc1ccc2c(c1)C(=C(c1ncc[nH]1)c1ccc(cc1)Cl)C(=O)N2,"InChI=1S/C25H26ClN5O/c1-2-31-13-9-18(10-14-31)29-19-7-8-21-20(15-19)23(25(32)30-21)22(24-27-11-12-28-24)16-3-5-17(26)6-4-16/h3-8,11-12,15,18,29H,2,9-10,13-14H2,1H3,(H,27,28)(H,30,32)",XHCPCYVQXFHJAU-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.38,,IC50,,4.2,,=,,,,22765894,
kinase insert domain receptor,1813,P35968,Human,CEP-11981,8189,,11751922,CC(Cn1c2ccc(cc2c2c1c1CCc3c(c1c1c2CNC1=O)cn(n3)C)Nc1ncccn1)C,"InChI=1S/C28H27N7O/c1-15(2)13-35-22-8-5-16(32-28-29-9-4-10-30-28)11-18(22)24-19-12-31-27(36)25(19)23-17(26(24)35)6-7-21-20(23)14-34(3)33-21/h4-5,8-11,14-15H,6-7,12-13H2,1-3H3,(H,31,36)(H,29,30,32)",AEULIVPVIDOLIN-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.4,,IC50,,4.0,,=,,,,22148921,
kinase insert domain receptor,1813,P35968,Human,ZM-306416,8245,,5329006,COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1F)Cl,"InChI=1S/C16H13ClFN3O2/c1-22-14-6-10-13(7-15(14)23-2)19-8-20-16(10)21-12-4-3-9(17)5-11(12)18/h3-8H,1-2H3,(H,19,20,21)",YHUIUSRCUKUUQA-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.0,,IC50,,100.0,,=,,,,10639280,
kinase insert domain receptor,1813,P35968,Human,pexidartinib,8710,,25151352,Clc1cnc2c(c1)c(c[nH]2)Cc1ccc(nc1)NCc1ccc(nc1)C(F)(F)F,"InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)",JGWRKYUXBBNENE-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.36,,IC50,,440.0,,=,,,,26222558,
kinase insert domain receptor,1813,P35968,Human,erdafitinib,9039,,67462786,COc1cc(OC)cc(c1)N(c1ccc2c(c1)nc(cn2)c1cnn(c1)C)CCNC(C)C,"InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3",OLAHOMJCDNXHFI-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.44,,IC50,,36.3,,=,,,,,
kinase insert domain receptor,1813,P35968,Human,glesatinib,9133,,25181472,COCCNCc1cnc(cc1)c1cc2nccc(c2s1)Oc1c(cc(cc1)NC(=S)NC(=O)Cc1ccc(cc1)F)F,"InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)",YRCHYHRCBXNYNU-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.0,,IC50,,10.0,,=,,,,18434145,
kinase insert domain receptor,1813,P35968,Human,altiratinib,9174,,54576299,O=C(C1CC1)Nc1nccc(c1)Oc1cc(F)c(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F,"InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)",GNNDEPIMDAZHRQ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.04,,IC50,,9.2,,=,,,,,
kinase insert domain receptor,1813,P35968,Human,OSI-930,9383,,9868037,O=C(c1sccc1NCc1ccnc2c1cccc2)Nc1ccc(cc1)OC(F)(F)F,"InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29)",FGTCROZDHDSNIO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.05,,IC50,,9.0,,=,,,,16424037,
kinase insert domain receptor,1813,P35968,Human,fruquintinib,9428,,44480399,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC,"InChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25)",BALLNEJQLSTPIO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.6,,IC50,,25.0,,=,Evaluated in a Z-lyte assay.,,,25482937,
kinase insert domain receptor,1813,P35968,Human,fruquintinib,9428,,44480399,CNC(=O)c1c(C)oc2c1ccc(c2)Oc1ncnc2c1cc(OC)c(c2)OC,"InChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25)",BALLNEJQLSTPIO-UHFFFAOYSA-N,Inhibitor,Inhibition,,,yes,,pIC50,,7.46,,IC50,,35.0,,=,Evaluated in a [<sup>32</sup>]p-ATP incorporation assay,,,25482937,
kinase insert domain receptor,1813,P35968,Human,MLKL compound 1,9513,,5329829,O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C,"InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)",SNRUTMWCDZHKKM-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.7,,IC50,,2.0,,=,,,,15990302,
kinase insert domain receptor,1813,P35968,Human,mivavotinib,9600,,53252276,N[C@H]1CCCC[C@H]1Nc1nc(c2cnn(c2)C)c2c(c1F)CNC2=O,"InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1",MJHOMTRKVMKCNE-NWDGAFQWSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.87,,IC50,,135.0,,=,Measured in a caliper-based electrophoretic mobility shift assay.,,,27839918,
kinase insert domain receptor,1813,P35968,Human,catequentinib,9601,,25017411,COc1cc2c(ccnc2cc1OCC1(N)CC1)Oc1ccc2c(c1F)cc([nH]2)C,"InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3",KSMZEXLVHXZPEF-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.35,,IC50,,45.0,,=,<i>In vitro</i> activity,,,,
kinase insert domain receptor,1813,P35968,Human,surufatinib,9769,,52920501,CN(CCNS(=O)(=O)Cc1cccc(c1)Nc1nccc(n1)Oc1ccc2c(c1)cc([nH]2)C)C,"InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)",TTZSNFLLYPYKIL-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.68,,IC50,,21.0,,=,In a biochemical assay using recombinant KDR kinase catalytic domain.,,,,
kinase insert domain receptor,1813,P35968,Human,compound 8i [PMID: 22765894],9905,,10433653,CCN1CCC(CC1)Nc1ccc2c(c1)/C(=C(/c1ncc([nH]1)C)\c1cccc(c1)F)/C(=O)N2,"InChI=1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23-",DMQYDVBIPXAAJA-VHXPQNKSSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.59,,IC50,,2.6,,=,,,,21613405,
kinase insert domain receptor,1813,P35968,Human,compound 8i [PMID: 22765894],9905,,10433653,CCN1CCC(CC1)Nc1ccc2c(c1)/C(=C(/c1ncc([nH]1)C)\c1cccc(c1)F)/C(=O)N2,"InChI=1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23-",DMQYDVBIPXAAJA-VHXPQNKSSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.4,,IC50,,4.0,,=,,,,22765894,
kinase insert domain receptor,1813,P35968,Human,ilorasertib,9914,,46207586,OCCn1ncc(c1)c1cnc(c2c1scc2c1ccc(cc1)NC(=O)Nc1cccc(c1)F)N,"InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)",WPHKIQPVPYJNAX-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.7,,IC50,,2.0,,=,Measuring inhibition of kinase activity in a biochemical assay.,,,22935731,
kinase insert domain receptor,1813,P35968,Human,sitravatinib,9920,,25212148,COCCNCc1ccc(nc1)c1sc2c(c1)nccc2Oc1ccc(cc1F)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F,"InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)",WLAVZAAODLTUSW-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.3,,IC50,,5.0,,=,In a biochemical enzyme activity assay.,,,26675259,
kinase insert domain receptor,1813,P35968,Human,tafetinib,9921,,56935577,CCN(CCNC(=O)c1c(C)[nH]c2c1CCC/C/2=C\1/C(=O)Nc2c1cc(F)cc2)CC,"InChI=1S/C24H29FN4O2/c1-4-29(5-2)12-11-26-23(30)20-14(3)27-22-16(20)7-6-8-17(22)21-18-13-15(25)9-10-19(18)28-24(21)31/h9-10,13,27H,4-8,11-12H2,1-3H3,(H,26,30)(H,28,31)/b21-17-",KGSRYTUWXUESJK-FXBPSFAMSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.3,,IC50,,5.0,,=,In a radiometric biochemical protein kinase assay.,,,21638122,
kinase insert domain receptor,1813,P35968,Human,cenisertib,9927,,11569967,CN1CCN(CC1)c1ccc(cc1C)Nc1ncc(c(n1)N[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)N)C2)F,"InChI=1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)/t15-,16+,20+,21-/m1/s1",KSOVGRCOLZZTPF-QMKUDKLTSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.02,,IC50,,95.0,,=,In a biochemical homogeneous time-resolved fluorescence (HTRF) kinase assay with an ATP concentration of 1 mM.,,,22695126,
kinase insert domain receptor,1813,P35968,Human,henatinib,9930,,25116064,O[C@@H](CN1CCCc2c(C1=O)c(C)c([nH]2)/C=C/1\C(=O)Nc2c1cc(F)cc2)CN1CCOCC1,"InChI=1S/C25H29FN4O4/c1-15-22(12-19-18-11-16(26)4-5-20(18)28-24(19)32)27-21-3-2-6-30(25(33)23(15)21)14-17(31)13-29-7-9-34-10-8-29/h4-5,11-12,17,27,31H,2-3,6-10,13-14H2,1H3,(H,28,32)/b19-12-/t17-/m1/s1",MCTXSDCWFQAGFS-UEXNTNOUSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.57,,IC50,,27.0,,=,,,,21028894,
kinase insert domain receptor,1813,P35968,Human,pralsetinib,10033,,129073603,CO[C@@]1(CC[C@@H](CC1)c1nc(C)cc(n1)Nc1n[nH]c(c1)C)C(=O)N[C@H](c1ccc(nc1)n1ncc(c1)F)C,"InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27+/m0/s1",GBLBJPZSROAGMF-RWYJCYHVSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.46,,IC50,,35.0,,=,In a biochemical assay.,,,29657135,
kinase insert domain receptor,1813,P35968,Human,GSK2646264,10108,,,COc1cccc(c1C1=CC2C(C=C1)CCNCC2)OCc1nccc(c1)C,"InChI=1S/C24H28N2O2/c1-17-8-13-26-21(14-17)16-28-23-5-3-4-22(27-2)24(23)20-7-6-18-9-11-25-12-10-19(18)15-20/h3-8,13-15,18-19,25H,9-12,16H2,1-2H3",CQLSAYKHANAIMX-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,4.5,,IC50,,31622.0,,=,,,,30249354,
kinase insert domain receptor,1813,P35968,Human,lazertinib,10136,,121269225,C=CC(=O)Nc1cc(Nc2nccc(n2)n2cc(c(n2)c2ccccc2)CN(C)C)c(cc1N1CCOCC1)OC,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",RRMJMHOQSALEJJ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.0,,IC50,,1000.0,,>,In a biochemical enzyme activity assay.,,,,
kinase insert domain receptor,1813,P35968,Human,compound 19a [PMID: 30503936],10181,,,CCN1CCN(CC1)CCCOc1cc2nccc(c2cc1OC)Oc1c(F)cc(cc1F)NC(=O)NN1C(=O)CSC1c1c(F)cccc1F,"InChI=1S/C35H36F4N6O5S/c1-3-43-11-13-44(14-12-43)10-5-15-49-30-19-27-22(18-29(30)48-2)28(8-9-40-27)50-33-25(38)16-21(17-26(33)39)41-35(47)42-45-31(46)20-51-34(45)32-23(36)6-4-7-24(32)37/h4,6-9,16-19,34H,3,5,10-15,20H2,1-2H3,(H2,41,42,47)",GZVQZLVAKXRTHU-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,6.07,,IC50,,850.0,,=,,,,30503936,
kinase insert domain receptor,1813,P35968,Human,RG-1530,10361,,135398512,COc1cc2[nH]c3n[nH]c(c3nc(c2cc1F)c1ccccc1Cl)C,"InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)",UOVCGJXDGOGOCZ-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKd,,7.82,,Kd,,15.0,,=,,,,20814247,
kinase insert domain receptor,1813,P35968,Human,compound T.14,10385,,,COc1ccc(cc1)/C=C/c1cccc(c1)NC(=O)Nc1ccc(cc1)Cl,"InChI=1S/C22H19ClN2O2/c1-27-21-13-7-16(8-14-21)5-6-17-3-2-4-20(15-17)25-22(26)24-19-11-9-18(23)10-12-19/h2-15H,1H3,(H2,24,25,26)/b6-5+",VGWVPSZVSVONQT-AATRIKPKSA-N,Inhibitor,Inhibition,,,,,,,,,,,,,=,,,,30878834,
kinase insert domain receptor,1813,P35968,Human,pamufetinib,10460,,44247727,CNC(=O)c1cc2c(ccnc2cc1OC)Oc1ccc(cc1F)NC(=S)NC(=O)Cc1ccccc1,"InChI=1S/C27H23FN4O4S/c1-29-26(34)19-14-18-21(15-24(19)35-2)30-11-10-22(18)36-23-9-8-17(13-20(23)28)31-27(37)32-25(33)12-16-6-4-3-5-7-16/h3-11,13-15H,12H2,1-2H3,(H,29,34)(H2,31,32,33,37)",ORRNXRYWGDUDOG-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pKi,,7.92,,Ki,,12.0,,=,,,,24140932,
kinase insert domain receptor,1813,P35968,Human,pegdinetanib,10472,,,,,,Inhibitor,Inhibition,,,,,pKd,,9.0,,Kd,,1.0,,~,,,,16720276,
kinase insert domain receptor,1813,P35968,Human,ibcasertib,10475,,49779393,COc1ccc2c(c1)nccc2Oc1ccc2c(c1)cccc2C(=O)Nc1ccccc1N,"InChI=1S/C27H21N3O3/c1-32-18-9-12-22-25(16-18)29-14-13-26(22)33-19-10-11-20-17(15-19)5-4-6-21(20)27(31)30-24-8-3-2-7-23(24)28/h2-16H,28H2,1H3,(H,30,31)",BRKWREZNORONDU-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.15,,IC50,,7.0,,=,Inhibition in a biochemical assay.,,,28004478,
kinase insert domain receptor,1813,P35968,Human,telatinib,10476,,9808844,CNC(=O)c1nccc(c1)COc1nnc(c2c1occ2)Nc1ccc(cc1)Cl,"InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)",QFCXANHHBCGMAS-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.0,,IC50,,100.0,,<,,,,,
kinase insert domain receptor,1813,P35968,Human,toceranib,11619,,5329106,Fc1ccc2c(c1)/C(=C/c1[nH]c(c(c1C)C(=O)NCCN1CCCC1)C)/C(=O)N2,"InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-",SRSGVKWWVXWSJT-ATVHPVEESA-N,Inhibitor,Inhibition,,,,,pKi,,8.22,,Ki,,6.0,,=,,,,12091352,
kinase insert domain receptor,1813,P35968,Human,ningetinib,11624,,60165029,Fc1cc(ccc1Oc1ccnc2c1ccc(c2)OCC(O)(C)C)NC(=O)c1c(C)n(n(c1=O)c1ccccc1)C,"InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(35(19)4)21-8-6-5-7-9-21)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(11-12-23(25)26)40-18-31(2,3)39/h5-17,39H,18H2,1-4H3,(H,34,37)",VQYYQSZNRVQLIS-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.43,,IC50,,37.0,,=,,,,,
kinase insert domain receptor,1813,P35968,Human,SU5402,11743,,5289418,Cc1c[nH]c(c1CCC(=O)O)/C=C\1/c2ccccc2NC1=O,"InChI=1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8-",JNDVEAXZWJIOKB-JYRVWZFOSA-N,Inhibitor,Inhibition,,,,,pIC50,,7.7,,IC50,,20.0,,=,,,,10602697,
kinase insert domain receptor,1813,P35968,Human,tinengotinib,11887,,137279257,Clc1c(cccc1)c1c2c([nH]c3c(n1)c(n[nH]3)C)cc(nc2)N1CCOCC1,"InChI=1S/C20H19ClN6O/c1-12-18-20(26-25-12)23-16-10-17(27-6-8-28-9-7-27)22-11-14(16)19(24-18)13-4-2-3-5-15(13)21/h2-5,10-11H,6-9H2,1H3,(H2,23,25,26)",DQFCVOOFMXEPOC-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.6,,IC50,,2.5,,=,,,,,
